Skip to main content
. 2021 Apr 29;184(9):2348–2361.e6. doi: 10.1016/j.cell.2021.02.037

Figure 2.

Figure 2

Neutralization of Victoria and B.1.351 viruses by convalescent plasma

Plasma was collected in the UK before June 2020, during the first wave of SARS-CoV-2, in the early convalescent phase 4–9 weeks following admission to hospital.

(A) FRNT assays comparing neutralization of Victoria (orange) and B.1.351 (green) (n = 34).

(B) Neutralization assays of Victoria and B.1.351 with plasma obtained from patients suffering B.1.1.7 infection at the indicated times following infection.

(C and D) Comparison of FRNT50 titers between B.1.351 and Victoria strains for convalescent and B.1.1.7 plasma, respectively. The Wilcoxon matched-pairs signed rank sum test was used for the analysis and two-tailed p values were calculated; geometric mean values are indicated above each column. The data underpinning the Victoria neutralization curves have been previously reported (Supasa et al., 2021). Individual FRNT50 values are shown in Table S1.